TrialThe journal of spinal cord medicine2025

Transcutaneous neuromodulation versus oxybutynin for neurogenic detrusor overactivity in persons with spinal cord injury: A randomized, investigator blinded, parallel group, non-inferiority controlled trial.

Samantak Sahu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.